This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Mitoxantrone Injection USP (2015-08-27)
- Starting date:
- August 27, 2015
- Posting date:
- September 2, 2015
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-54906
Affected Products
Mitoxantrone Injection USP
Reason
Product may not support the specification results for known impurity prior to expiry.
Depth of distribution
Hospitals (Including pharmacies)
Affected products
Mitoxantrone Injection USP
DIN, NPN, DIN-HIM
DIN 02244614
Dosage form
Solution
Strength
Mitoxantrone 2 mg/mL
Lot or serial number
B024636AAR
B034636AD
C014636AC
Companies
- Recalling Firm
-
Hospira Healthcare Corporation
2600 Alfred Nobel Blvd, Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA
- Marketing Authorization Holder
-
Hospira Healthcare Corporation
2600 Alfred Nobel Blvd, Suite 500
Saint-Laurent
H4S 0A9
Quebec
CANADA